Latest Articles : Hepatology

Secondary Logo

Journal Logo

Latest Articles

The Editors of this journal are pleased to offer electronic publication of accepted papers prior to print publication: 1. as pre-typeset and unedited ‘ACCEPTED MS’ and 2.  in their final form as ‘EARLY VIEW’ final pdfs. ​These papers can be cited using the date of access and the unique DOI number. Any final changes in manuscripts will be made at the time of print publication and will be reflected in the final electronic version of the issue.

Disclaimer: Articles appearing in this Latest Articles section have been peer-reviewed and accepted for publication in this journal and posted online before print publication. Articles appearing here may contain statements, opinions, and information that have errors in facts, figures, or interpretation. Accordingly, Lippincott Williams & Wilkins, the editors and authors and their respective employees are not responsible or liable for the use of any such inaccurate or misleading data, opinion or information contained the articles in this section.

Latest Articles are available in PDF format only.

PRACTICE GUIDANCE

AASLD practice guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma

Singal, Amit G.; Llovet, Josep M.; Yarchoan, Mark; More

  • PAP
  • ACCEPTED MS

Original

Magnetic resonance Elastography-Based prediction model for hepatic decompensation in NAFLD; a Multi-Center cohort study

Kim, Beom Kyung; Bergstrom, Jaclyn; Loomba, Rohan; More

Correspondence

Letter to the editor: People living with HIV and NAFLD: A population left behind in the global effort for liver fibrosis screening?

Sebastiani, Giada; Milic, Jovana; Tsochatzis, Emmanuel A.; More

  • PAP
  • ACCEPTED MS

Original

Etiological cure prevents further decompensation and mortality in cirrhotic patients with ascites as the single first decompensating event

Tonon, Marta; Balcar, Lorenz; Semmler, Georg; More

Original

Antiviral therapy substantially reduces hepatocellular carcinoma risk in chronic Hepatitis B patients in the indeterminate phase

Huang, Daniel Q.; Tran, Andrew; Yeh, Ming-Lun; More

Original

Tropifexor plus cenicriviroc combination versus monotherapy in non-alcoholic steatohepatitis: Results from the Phase 2b TANDEM study

Anstee, Quentin M; Lucas, Kathryn J.; Francque, Sven; More

Original

Single-cell RNA sequencing of liver fine-needle aspirates captures immune diversity in the blood and liver in chronic hepatitis B patients

Genshaft, Alex S.; Subudhi, Sonu; Keo, Arlin; More

Original

Bile exosomal miR-182/183-5p increases cholangiocarcinoma stemness and progression by targeting HPGD and increasing PGE2 generation

Shu, Lizhuang; Li, Xingyong; Liu, Zengli; More

Original

Targeting hepatic serine-arginine protein kinase 2 ameliorates alcohol-associated liver disease by alternative splicing control of lipogenesis

Li, Guannan; Chen, Hanqing; Shen, Feng; More

Original

Head-to-head comparison of MR elastography-based liver stiffness, fat Fraction, and T1 relaxation time in identifying At-Risk NASH

Li, Jiahui; Lu, Xin; Zhu, Zheng; More

Original

Intratumoural microbial heterogeneity affected tumor immune microenvironment and determined clinical outcome of HBV-related hepatocellular carcinoma

Li, Shengnan; Xia, Han; Wang, Zeyu; More

Original

Duration of type 2 diabetes and liver-related events in nonalcoholic fatty liver disease: A landmark analysis

Zhang, Xinrong; Yip, Terry Cheuk-Fung; Tse, Yee-Kit; More

Review

Pathway to global elimination of hepatitis B: HBV cure is just the first step

Howell, Jessica; Seaman, Chris; Wallace, Jack; More

Original

Class a capsid assembly modulator RG7907 clears HBV-infected hepatocytes through core-dependent hepatocyte death and proliferation

Kum, Dieudonné Buh; Vanrusselt, Hannah; Acosta Sanchez, Abel; More

Original

Use of HBV RNA and hepatitis B core-related antigen to predict change in serological status and disease activity in CHB

Ghany, Marc G.; King, Wendy C.; Hinerman, Amanda S.; More

Original

The global Fatty Liver Disease-Sustainable Development Goal country score for 195 countries and territories

Lazarus, Jeffrey V.; Han, Hannah; Mark, Henry E.; More

Original

Semaphorin 3C exacerbates liver fibrosis

De Angelis Rigotti, Francesca; Wiedmann, Lena; Hubert, Max Ole; More

Original

Identification and characterisation of a hepatic IL-13 producing ILC3-like population potentially involved in liver fibrosis

Raabe, Jan; Kaiser, Kim M.; ToVinh, Michael; More

Original

Antisense oligonucleotide silencing of a glycosyltransferase, Poglut1, improves the liver phenotypes in mouse models of Alagille syndrome

Niknejad, Nima; Fox, Duncan; Burwinkel, Jennifer L.; More

Original

Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis: ENHANCE, a phase 3, randomized, placebo-controlled study

Hirschfield, Gideon M.; Shiffman, Mitchell L.; Gulamhusein, Aliya; More